Document is current
Any future updates will be listed below
-
Authors
Simonet, Nicolas G.
Thackray, Joshua K.
Kesner, Barry
Guitart-Solanes, Anna
Serra, François https://orcid.org/0000-0003-3895-4742
Espinosa-Alcantud, Maria
Lappala, Anna
Marín-Gual, Laia https://orcid.org/0000-0003-1480-0976
Marín-García, Cristina
Weissbein, Uri
Castelló-García, Josema
Bauer, Moritz
Wang, Danni
Rovirosa, Llorenç
Tischfield, Jay
Serrano, Lourdes
Payer, Bernhard
Ruiz-Herrera, Aurora https://orcid.org/0000-0003-3868-6151
Vazquez, Berta N.
Javierre, Biola M.
Vaquero, Alejandro https://orcid.org/0000-0002-8735-4156
Lee, Jeannie T. https://orcid.org/0000-0001-7786-8850
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 12 May 2026
First Online: 10 June 2026
Competing interests
: J.T.L. is a non-executive director of GlaxoSmithKline and a cofounder of Fulcrum Therapeutics, and serves on the scientific advisory board of Skyhawk Therapeutics. The other authors declare no competing interests.
